We applied FAVR principles, described herein, to identify that rare mutations in XRCC2 increase the risk of human breast cancer, which is to our knowledge the first published report of massively parallel sequencing (MPS) being successfully applied to identify a new complex human disease gene[1]. Here, XRCC2 is linked to breast carcinoma.